Vedolizumab for the Treatment of Crohn’s Disease and Ulcerative Colitis

Abstract

Crohn’s disease (CD) and ulcerative colitis (UC) are characterized by migration of inflammatory cells into the intestinal mucosa triggered by a dysregulated immune response involving T lymphocytes, macrophages, neutrophils, interleukins, a...